Proteochemometric modeling of HIV protease susceptibility
Open Access
- 10 April 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Bioinformatics
- Vol. 9 (1), 181
- https://doi.org/10.1186/1471-2105-9-181
Abstract
A major obstacle in treatment of HIV is the ability of the virus to mutate rapidly into drug-resistant variants. A method for predicting the susceptibility of mutated HIV strains to antiviral agents would provide substantial clinical benefit as well as facilitate the development of new candidate drugs. Therefore, we used proteochemometrics to model the susceptibility of HIV to protease inhibitors in current use, utilizing descriptions of the physico-chemical properties of mutated HIV proteases and 3D structural property descriptions for the protease inhibitors. The descriptions were correlated to the susceptibility data of 828 unique HIV protease variants for seven protease inhibitors in current use; the data set comprised 4792 protease-inhibitor combinations. The model provided excellent predictability (R 2 = 0.92, Q 2 = 0.87) and identified general and specific features of drug resistance. The model's predictive ability was verified by external prediction in which the susceptibilities to each one of the seven inhibitors were omitted from the data set, one inhibitor at a time, and the data for the six remaining compounds were used to create new models. This analysis showed that the over all predictive ability for the omitted inhibitors was Q 2 inhibitors = 0.72. Our results show that a proteochemometric approach can provide generalized susceptibility predictions for new inhibitors. Our proteochemometric model can directly analyze inhibitor-protease interactions and facilitate treatment selection based on viral genotype. The model is available for public use, and is located at HIV Drug Research Centre.Keywords
This publication has 32 references indexed in Scilit:
- A Look Inside HIV Resistance through Retroviral Protease Interaction MapsPLoS Computational Biology, 2007
- A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance MechanismPLoS Medicine, 2007
- Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactionsProteins: Structure, Function, and Bioinformatics, 2006
- Computational methods for the design of effective therapies against drug resistant HIV strainsBioinformatics, 2005
- Proteochemometrics: A Tool for Modeling the Molecular Interaction SpacePublished by Wiley ,2004
- Multidrug Resistance to HIV-1 Protease Inhibition Requires Cooperative Coupling between Distal MutationsBiochemistry, 2003
- Non‐parametric methods to predict HIV drug susceptibility phenotype from genotypeStatistics in Medicine, 2003
- A Major Role for a Set of Non-Active Site Mutations in the Development of HIV-1 Protease Drug ResistanceBiochemistry, 2003
- Better Bootstrap Confidence IntervalsJournal of the American Statistical Association, 1987
- Partial least-squares regression: a tutorialAnalytica Chimica Acta, 1986